Fully stereocontrolled total syntheses of the prostacyclin analogues 16S-iloprost and 16S-3-oxa-iloprost by a common route, using alkenylcopper-azoalkene conjugate addition, asymmetric olefination, and allylic alkylation

被引:33
作者
Kramp, GJ [1 ]
Kim, M [1 ]
Gais, HJ [1 ]
Vermeeren, C [1 ]
机构
[1] Rhein Westfal TH Aachen, Inst Organ Chem, D-52056 Aachen, Germany
关键词
D O I
10.1021/ja0558037
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In this article we describe fully stereocontrolled total syntheses of 16S-iloprost (16S-2), the most active component of the drugs Ilomedin and Ventavis, and of 16S-3-oxa-iloprost (16S-3), a close analogue of 16S-2 having the potential for a high oral activity, by a new and common route. The key steps of this route are (1) the establishment of the complete C13-C20 omega side chain of the target molecules through a stereoselective conjugate addition of the alkenylcopper derivative 9 to the bicyclic C6-C12 azoalkene 10 with formation of hydrazone 8, (2) the diastereoselective olefination of ketone 7 with the chiral phosphoryl acetate 39, and (3) the regio- and stereoselective alkylation of the allylic acetate 43 with cuprate 42. These measures allowed the 5E,15S,16S-stereoselective synthesis of 16S-2 and 16S-3, a goal which had previously not been achieved. Azoalkene 10 was obtained from the achiral bicyclic C6-C12 ketone 11 as previously described by using as key step an enantioselective deprotonation. The configuration at C16 of omega-side chain building block 9 has been installed with high stereoselectivity by the oxazolidinone method and that at C15 by a diastereoselective oxazaborolidine-catalyzed reduction of the C13-C20 ketone 23 with catecholborane. Surprisingly, a high diastereoselectivity in the reduction of 23 was only obtained by using 2 equiv of oxazaborolidine 24. Application of substoichiometric amounts of 24 resulted in irreproducible diastereoselectivities ranging from very high to nil.
引用
收藏
页码:17910 / 17920
页数:11
相关论文
共 112 条
[1]   Treatment of bone-marrow oedema of the talus with the prostacyclin analogue iloprost - An MRI-controlled investigation of a new method [J].
Aigner, N ;
Petje, G ;
Steinboeck, G ;
Schneider, W ;
Krasny, C ;
Landsiedl, F .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2001, 83B (06) :855-858
[2]   COMPARISON OF ILOPROST, CICAPROST AND PROSTACYCLIN EFFECTS ON CYCLIC-AMP METABOLISM IN INTACT PLATELETS [J].
ASHBY, B .
PROSTAGLANDINS, 1992, 43 (03) :255-261
[3]   Prostanoid therapy for pulmonary arterial hypertension [J].
Badesch, DB ;
McLaughlin, VV ;
Delcroix, M ;
Vizza, CD ;
Olschewski, H ;
Sitbon, O ;
Barst, RJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :56S-61S
[4]   ON THE REACTIONS OF BENZENESELENINIC ANHYDRIDE WITH MONOSUBSTITUTED HYDRAZONES - EVIDENCE FOR RADICAL PATHWAYS [J].
BARTON, DHR ;
OKANO, T ;
PAREKH, SI .
TETRAHEDRON, 1991, 47 (10-11) :1823-1836
[5]  
BARTON DHR, 1998, MOL ONLINE, V2, P22
[6]  
BERTZ SH, 1986, ORG SYNTH, V64, P27
[7]  
Biasi D, 1998, REV RHUM, V65, P745
[8]  
BRUCHHAUSEN F, 1997, PLATELETS THEIR FACT
[9]  
Bund J, 1998, EUR J ORG CHEM, V1998, P1319
[10]  
CACCHI S, 1978, CHIM IND-MILAN, V60, P715